α-Synuclein propagation leads to synaptic abnormalities in the cortex through microglial synapse phagocytosisDayana Perez Acuna, Soo Jean Shin, Ka Hyun Lee et al.
Accumulation of phospho-alpha synuclein and oligomeric tau in presynapses in Parkinson’s disease and Dementia with Lewy BodiesElizabeth Simzer, Yuting Zhang, Kristjan Holt et al.via dementia with Lewy bodies
Autophagy modulation of glial neuroinflammatory responses in Parkinson’s diseaseShiza Shaikh, Lucy Crompton, Jon Lane
Choroid plexus volume as a proxy for neuroinflammation – evaluation of its trans-diagnostic, prognostic, and therapeutic biomarker potential in parkinsonismLiucija Vaicenaviciute, Lennart Spindler, Kirsten Scott, Caroline Williams-Grayvia dementia with Lewy bodies
Development of a novel viral vector-based model of dementia with Lewy bodies in miceYaprak Karabalci, Lilya Andrianova, Michael T Craigvia dementia with Lewy bodies
Differences in the synaptic function of human and murine alpha-synucleinJen Riba, Alexandra Stavsky, Daniel Gitler
Early hippocampal hyperexcitability and mitochondrial changes in a transgenic mouse model of dementia with Lewy bodiesLauren O'Neill, Chun Chen, Bethany Dennis et al.via dementia with Lewy bodies
Effects of alpha-synuclein on dopamine and serotonin transportersIina Ludwig, Michael Connor, Thomas Steinkellner
Evidence of prodromal neuronal hyperexcitability and neuroinflammation in a rodent model of human alpha-synucleinopathyIbtisam Al Musawi, Gavin Clowry, Fiona Lebeauvia dementia with Lewy bodies
Exploring the combinatorial, diagnostic utility of multimodal biomarkers in differentially diagnosing Dementia with Lewy Bodies from Alzheimer’s through predictive statistical modellingKatherine Birditt, Leonidas Chouliarasvia dementia with Lewy bodies
Fighting against Parkinson's disease with a new SGK1 inhibitorLilia Smith, Enrique Madruga-Mayordomo, Ana Martínez, Isabel Lastres-Becker
Functional, behavioural and molecular characterization of a presymptomatic model of Parkinson disease expressing α-synuclein in the locus coeruleusJone Razquin, Laura De Las Heras-García, Celtia Domínguez-Fernández et al.
Influence of the APOE4 risk factor on hippocampal epigenetic and transcriptomic signatures in a physiological and pathological environment indicative of dementia with Lewy bodies (DLB)Iris Grgurina, Isabel Paiva, Stephanie Le Gras et al.
Investigating changes in interneurons and perineuronal nets in a rodent model of alpha-synucleinopathyAnastasia Dimitriou, Bethany Dennis, Gavin Clowry, Fiona LeBeauvia dementia with Lewy bodies
The locus coeruleus noradrenergic network in prodromal phases of Parkinson’s diseaseLaura De las Heras-García, Jone Razquin, Celtia Domínguez-Fernández et al.
miR-302 induced by glucagon-like peptide-1 (GLP-1) signaling reduces the α-synuclein neurotoxicity linked to dementia with Lewy bodies (DLB)Chih-Li Lin, Sing-Hua Tsou, Ching-Chi Chang et al.via dementia with Lewy bodies
Novel insights in oligodendroglia as a key cell type in Parkinson’s diseaseJuan Manuel Barba Reyes, Lisbeth Harder, Mónica Díez Salguero et al.
Pharmacological modulation of Nrf2 pathway in alpha-synuclein mouse model of Parkinson’s diseaseMichela Salvadè, Elisa Zianni, Maria Italia et al.
The role of EEF1A proteins at synapses and in synucleinopathySarka Jelinkova, Lou Bouit, David Perrais et al.via dementia with Lewy bodies
Synergistic effects of α-synuclein, tau, and amyloid pathology on mitophagy in dementia with Lewy bodiesWolfdieter Springer, Xu Hou, Tyrique Richardson et al.via dementia with Lewy bodies
A new technique to measure implicit line orientation discrimination using fast periodic visual stimulation (FPVS)Oliver Hermann, Carla Leonardi, Karin Petrini et al.via dementia with Lewy bodies
Thorough behavioural characterization of zebrafish models across Parkinson's disease progressionTanita Maria Tzotzolaki, Francois-Xavier Lejeune, Jessica Garcia Fernandez et al.